chiniofon and Endophthalmitis

chiniofon has been researched along with Endophthalmitis* in 1 studies

Other Studies

1 other study(ies) available for chiniofon and Endophthalmitis

Article	Year
Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit. Journal of ocular pharmacology, 1985,Winter, Volume: 1, Issue:4 Among all lipoxygenase inhibitors studied, REV 5901 was found to be the most potent one to reduce lens protein-induced ocular inflammation in rabbits. It reduced ocular inflammation effectively by either injection into the ear vein (10 mg/kg) (65% inhibition) or topical administration (50 microliters of 5% ointment) (40% inhibition). Local administration was less effective than intravenous injection presumably because of slower drug delivery into the eyes. Topics: Animals; Endophthalmitis; Female; Hydroxyquinolines; Infusions, Intravenous; Intraocular Pressure; Lipoxygenase Inhibitors; Ophthalmic Solutions; Quinolines; Rabbits	1985

Article

Year

Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit.

Journal of ocular pharmacology, 1985,Winter, Volume: 1, Issue:4

Among all lipoxygenase inhibitors studied, REV 5901 was found to be the most potent one to reduce lens protein-induced ocular inflammation in rabbits. It reduced ocular inflammation effectively by either injection into the ear vein (10 mg/kg) (65% inhibition) or topical administration (50 microliters of 5% ointment) (40% inhibition). Local administration was less effective than intravenous injection presumably because of slower drug delivery into the eyes.

Topics: Animals; Endophthalmitis; Female; Hydroxyquinolines; Infusions, Intravenous; Intraocular Pressure; Lipoxygenase Inhibitors; Ophthalmic Solutions; Quinolines; Rabbits

1985